Presentations -
-
多発性骨髄腫のIMIDs抵抗性メカニズムの解明
ICHIKAWA Daiju
第77回日本癌学会学術集会 (大阪国際会議場 大阪市) ,
2018.09,Poster presentation
-
Cereblon-independent anti-myeloma pathway of TC11, a novel compound of immunomodulatory drugs
Daiju Ichikawa, Shuji Aida, Nahoko Hashimoto, Wakana Murota, Ryo Uozaki, Mikio Okayama, Kota Fujimori, Yuko Yonemura, Noriko Tabata, Hiroshi Yanagawa, Maiko Matsushita, Yutaka Hattori
第79回日本血液学会,
2017.10,Oral presentation (general)
-
PEG(E)-TC11, a novel PEG phthalimide derivative, inhibited MM cell growth CRBN independent manner.
ICHIKAWA Daiju
第42回日本骨髄腫学会学術集会,
2017.05,Poster presentation
-
PEG(E)-TC11, a novel polyethylene glycol-linked phthalimide derivative, inhibited high-risk MM cell growth in vivo and in vitro via cell cycle G2/M arrest in a CRBN-independent manner.
Shuji Aida, Daiju Ichikawa, Kazuki Iida, Masashi Hozumi, Misa Nakamura, Ryo Uozaki, Nahoko Hashimoto, Mikio Okayama, Yuko Yonemura, Noriko Tabata, Taketo Yamada, Maiko Matsushita, Takeshi Sugai, Hiroshi Yanagawa, Yutaka Hattori
American association for cancer research annual meeting 2017,
2017.04,Poster presentation
-
Komaroviquinone-Derivatives, Revealed Anti-Tumor Effect on High-Risk Multiple Myeloma Cells In Vitro as Well as In Vivo
Mariko Sato, Kota Fujimori, Shotaro Kitabatake, Mikio Okayama, Daiju Ichikawa, Yutaka Suto, Genji Iwasaki, Fumiyuki Kiuchi, Takashi Yamaguchi, Arimi Ueda, Shuji Aida, Hitomi Nakayama, Maiko Matsushita, and Yutaka Hattori
ASH, 58th Annual Meeting & Exposition,
2016.12,Poster presentation
-
Structural optimization and anti-tumor activities of komaroviquinone to high-risk myeloma
ICHIKAWA Daiju
第78回日本血液学会学術集会,
2016.10,Oral presentation (general)
-
ハイリスク多発性骨髄腫に対する新規komaroviquinone誘導体による克服薬の開発
ICHIKAWA Daiju
第41回日本骨髄腫学会学術集会,
2016.05,Poster presentation
-
Drug Design for Overcoming High-Risk Myeloma and Identification of Novel Binding Proteins to Immune-Modulatory Drugs
ICHIKAWA DaijuMasashi Hozumi, Daiju Ichikawa, Maiko Matsushita, Eriko Kamiyama, Hiroshi Yanagawa, Noriko Tabata, Shotaro Kitabatake, Arimi Ueda, Takashi Yamaguchi, Mariko Sato, and Yutaka Hattori.
57th Annual Meeting and Exposition (Orlando, FL) ,
2015.12,Poster presentation
-
Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI.
Matsushita M, Koji Ozawa, Kanchi S, Uchiumi A, Suzuki T, Ichikawa D, Matsuski E, Sakurai M, Karigane D, Nakajima H, Okamoto S, Hattori Y.
30th Annual Meeting of The Society for Immunotherapy of Cancer（SITC） (National Harbor, MD.) ,
2015.11,Poster presentation
-
Identification of New IMiDs-Binding Proteins and Nonteratogenic Drug Design for High-Risk Myeloma
ICHIKAWA DaijuMasashi Hozumi, Maiko Matsushita, Daiju Ichikawa, Yoshie Ozaki, Yuka Hasegawa, Fukiko Terada, Hiroshi Yanagawa, Noriko Tabata, Hirokazu Shiheido, Tukasa Oikawa, Koichi Matsuo, Taketo Yamada, Wenlin Du, Shotaro Kitabatake, Arimi Ueda, Yutaka Hattori
第77回日本血液学会学術集会,
2015.10,Oral presentation (general)
-
イマチニブ投与中止後CML患者におけるがん幹細胞抗原特異的CTLの解析
ICHIKAWA Daiju
第７回血液疾患免疫療法研究会学術集会,
2015.09,Poster presentation
-
ハイリスク多発性骨髄腫に対する新規治療薬の開発
ICHIKAWA Daiju
16回 Pharmaco-Hematologyシンポジウム（日本薬学会生物系薬学部会),
2015.06,Oral presentation (general)
-
白血病幹細胞に発現する新規がん精巣抗原の同定
ICHIKAWA Daiju
第 12回日本免疫治療学研究会学術集会,
2015.02,Oral presentation (general)
-
Development of a Novel Phthalimide Derivative, Preclinical Effects on High-risk Myeloma Cells and Osteoclasts.
Hattori Y, Matsushita M, Tabata N, Shiheido H, Yanagawa H, Hozumi M, Ueda A, Kitabatake S, Ichikawa D.
56th AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition. (San Francisco, CA) ,
2014.12,Poster presentation
-
Clinical and biological significance of codon 72 polymorphism of TP53 gene in multiple myeloma.
Hozumi M, Ikeda Y, Suzuki Y, Matsushita M, Ichikawa D, Hattori Y.
第76回日本血液学会 (大阪) ,
2014.10,Oral presentation (general)
-
Identification of novel cancer-testis antigen expressed in leukemic stem cells of chronic myelogenous leukemia.
〇Matsushita M, Nakamura M, Ichikawa D, Tsukamoto N, Kawakami Y, Hattori Y.
43rd Annual Scientific Meeting of Society for Hematology and Stem Cells (Montreal, Canada) ,
2014.08 -
Codon 72 Polymorphism Of TP53 Gene Is a Novel Prognostic Marker For Thalidomide Therapy In Multiple Myeloma.
○Hattori Y, Ikeda Y, Suzuki Y, Ichikawa D, Matsushita M.
2013 Annual meeting of American Society of Hematology (New Orleans) ,
2013.12 -
Identification of novel cancer-testis antigen expressed in leukemic stem cells of chronic myelogenous leukemia.
Nakamura M, Matushita M, Ichikawa D, Tsukamoto N, Kawakami Y, Hattori Y.
第42回日本免疫学会総会 (幕張メッセ) ,
2013.12,Poster presentation
-
A myeloma cell line established from a patient refractory to thalidomide therapy.
○Ueda A, Matsunami S, Du W, Yamada T, Mori S, Ichikawa D, Matsushita M, Hattori Y.
第75回日本血液学会学術集会 (札幌) ,
2013.10 -
A myeloma cell line established from a patient refractory to thalidomide therapy.
Ueda A, Abe Y, Matsunami S, Du W, Yamada T, Shougo M, Ichikawa D, Matsushita M, Hattori Y.
第75回日本血液学会 (札幌教育文化会館) ,
2013.10,Oral presentation (general)